Integrated Quantitative Investments
MRVI icon

Integrated Quantitative Investments’s Maravai LifeSciences MRVI Stock Holding History

Integrated Quantitative Investments’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-146,065
Closed -$911K – 481
2026
Q2 		$911K Buy
+146,065
New +$631K 0.15% 235

Other funds holding MRVI

GTCR LLC
GTCR LLC Chicago, Illinois $4.29B AUM 4.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Integrated Quantitative Investments's MRVI Position: Q3 2026 in Review

Integrated Quantitative Investments sold out of Maravai LifeSciences (MRVI) in Q3 2026, closing a stake of 146,065 shares — an estimated $911K sold.

Integrated Quantitative Investments first reported a position in MRVI in Q2 2026 and held it in 1 quarter. The position peaked at $911K in Q2 2026. 146 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • Integrated Quantitative Investments reported no remaining Maravai LifeSciences position as of Q3 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 146,065 Maravai LifeSciences shares in Q3 2026, an estimated $911K.
  • Integrated Quantitative Investments first reported a position in Maravai LifeSciences in Q2 2026 and held it in 1 quarter.
  • Integrated Quantitative Investments's Maravai LifeSciences position peaked at $911K in Q2 2026.
  • 146 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Integrated Quantitative Investments's 13F filing for Q3 2026, filed 13 Nov 2026.